Combined-Modality Therapy With Gemcitabine and Radiotherapy As a Bladder Preservation Strategy: Results of a Phase I TrialElizabeth C. Kent, David C. Smith, Judith Fardig et al.|Journal of Clinical Oncology|2004Cited by 86
1417 EFFICIENT DELIVERY OF RADICAL CYSTECTOMY AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER: A MULTIDISCIPLINARY APPROACHAjjai Alva, Cheryl Lee, David C. Smith et al.|The Journal of Urology|2011Cited by 7
MP50-06 MICROPAPILLARY DIFFERENTIATION VERSUS CONVENTIONAL UROTHELIAL CARCINOMA: EFFECTS OF NEOADJUVANT CHEMOTHERAPY AND CYSTECTOMY ON SURVIVALNoah Canvasser, Jeffrey S. Montgomery, Alon Z. Weizer et al.|The Journal of Urology|2014Cited by 3
1766 LENGTH OF STAY FOLLOWING RADICAL CYSTECTOMY: HOW LONG IS LONG ENOUGH?Sapan N. Ambani, Todd M. Morgan, Alon Z. Weizer et al.|The Journal of Urology|2013Cited by 2
1405 RESULTS FROM A RANDOMIZED CONTROLLED STUDY OF PROSTATE CAPSULE SPARING (PCS) VERSUS NERVE SPARING (NS) CYSTECTOMY AND ORTHOTOPIC NEOBLADDER FOR UROTHELIAL CANCERAlon Z. Weizer, David P. Wood, James E. Montie et al.|The Journal of Urology|2012Cited by 0